Global Cold-chain Pharma 麻豆原创 Research Report 2023

Publication ID:

PB502233700

Publication Date:

February 7, 2023

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cold-chain Pharma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cold-chain Pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cold-chain Pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cold-chain Pharma in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cold-chain Pharma include Agility Public Warehousing Company KSCP, AmerisourceBergen Corporation, Cavalier Logistics, Continental AG, Deutsche Post AG, DSV A/S, FedEx Corporation, Helapet and JWD InfoLogistics Public, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cold-chain Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold-chain Pharma.
The Cold-chain Pharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cold-chain Pharma market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold-chain Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Agility Public Warehousing Company KSCP
AmerisourceBergen Corporation
Cavalier Logistics
Continental AG
Deutsche Post AG
DSV A/S
FedEx Corporation
Helapet
JWD InfoLogistics Public
Kerry Logistics Network Limited
Kuehne + Nagel Management AG
OOCL Logistics Limited
Orient Overseas International Ltd.
SCG Logistics
United Parcel Service
Segment by Type
Non-prescription Drugs
Prescription Drugs
Segment by Application
Hospital
Clinic
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold-chain Pharma companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cold-chain Pharma 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non-prescription Drugs
1.2.3 Prescription Drugs
1.3 麻豆原创 by Application
1.3.1 Global Cold-chain Pharma 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold-chain Pharma 麻豆原创 Perspective (2018-2029)
2.2 Cold-chain Pharma Growth Trends by Region
2.2.1 Global Cold-chain Pharma 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cold-chain Pharma Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Cold-chain Pharma Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Cold-chain Pharma 麻豆原创 Dynamics
2.3.1 Cold-chain Pharma Industry Trends
2.3.2 Cold-chain Pharma 麻豆原创 Drivers
2.3.3 Cold-chain Pharma 麻豆原创 Challenges
2.3.4 Cold-chain Pharma 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold-chain Pharma Players by Revenue
3.1.1 Global Top Cold-chain Pharma Players by Revenue (2018-2023)
3.1.2 Global Cold-chain Pharma Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Cold-chain Pharma 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold-chain Pharma Revenue
3.4 Global Cold-chain Pharma 麻豆原创 Concentration Ratio
3.4.1 Global Cold-chain Pharma 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold-chain Pharma Revenue in 2022
3.5 Cold-chain Pharma Key Players Head office and Area Served
3.6 Key Players Cold-chain Pharma Product Solution and Service
3.7 Date of Enter into Cold-chain Pharma 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold-chain Pharma Breakdown Data by Type
4.1 Global Cold-chain Pharma Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Cold-chain Pharma Forecasted 麻豆原创 Size by Type (2024-2029)
5 Cold-chain Pharma Breakdown Data by Application
5.1 Global Cold-chain Pharma Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Cold-chain Pharma Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Cold-chain Pharma 麻豆原创 Size (2018-2029)
6.2 North America Cold-chain Pharma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cold-chain Pharma 麻豆原创 Size by Country (2018-2023)
6.4 North America Cold-chain Pharma 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold-chain Pharma 麻豆原创 Size (2018-2029)
7.2 Europe Cold-chain Pharma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cold-chain Pharma 麻豆原创 Size by Country (2018-2023)
7.4 Europe Cold-chain Pharma 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold-chain Pharma 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Cold-chain Pharma 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cold-chain Pharma 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Cold-chain Pharma 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold-chain Pharma 麻豆原创 Size (2018-2029)
9.2 Latin America Cold-chain Pharma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cold-chain Pharma 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Cold-chain Pharma 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold-chain Pharma 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Cold-chain Pharma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cold-chain Pharma 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Cold-chain Pharma 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agility Public Warehousing Company KSCP
11.1.1 Agility Public Warehousing Company KSCP Company Detail
11.1.2 Agility Public Warehousing Company KSCP Business Overview
11.1.3 Agility Public Warehousing Company KSCP Cold-chain Pharma Introduction
11.1.4 Agility Public Warehousing Company KSCP Revenue in Cold-chain Pharma Business (2018-2023)
11.1.5 Agility Public Warehousing Company KSCP Recent Development
11.2 AmerisourceBergen Corporation
11.2.1 AmerisourceBergen Corporation Company Detail
11.2.2 AmerisourceBergen Corporation Business Overview
11.2.3 AmerisourceBergen Corporation Cold-chain Pharma Introduction
11.2.4 AmerisourceBergen Corporation Revenue in Cold-chain Pharma Business (2018-2023)
11.2.5 AmerisourceBergen Corporation Recent Development
11.3 Cavalier Logistics
11.3.1 Cavalier Logistics Company Detail
11.3.2 Cavalier Logistics Business Overview
11.3.3 Cavalier Logistics Cold-chain Pharma Introduction
11.3.4 Cavalier Logistics Revenue in Cold-chain Pharma Business (2018-2023)
11.3.5 Cavalier Logistics Recent Development
11.4 Continental AG
11.4.1 Continental AG Company Detail
11.4.2 Continental AG Business Overview
11.4.3 Continental AG Cold-chain Pharma Introduction
11.4.4 Continental AG Revenue in Cold-chain Pharma Business (2018-2023)
11.4.5 Continental AG Recent Development
11.5 Deutsche Post AG
11.5.1 Deutsche Post AG Company Detail
11.5.2 Deutsche Post AG Business Overview
11.5.3 Deutsche Post AG Cold-chain Pharma Introduction
11.5.4 Deutsche Post AG Revenue in Cold-chain Pharma Business (2018-2023)
11.5.5 Deutsche Post AG Recent Development
11.6 DSV A/S
11.6.1 DSV A/S Company Detail
11.6.2 DSV A/S Business Overview
11.6.3 DSV A/S Cold-chain Pharma Introduction
11.6.4 DSV A/S Revenue in Cold-chain Pharma Business (2018-2023)
11.6.5 DSV A/S Recent Development
11.7 FedEx Corporation
11.7.1 FedEx Corporation Company Detail
11.7.2 FedEx Corporation Business Overview
11.7.3 FedEx Corporation Cold-chain Pharma Introduction
11.7.4 FedEx Corporation Revenue in Cold-chain Pharma Business (2018-2023)
11.7.5 FedEx Corporation Recent Development
11.8 Helapet
11.8.1 Helapet Company Detail
11.8.2 Helapet Business Overview
11.8.3 Helapet Cold-chain Pharma Introduction
11.8.4 Helapet Revenue in Cold-chain Pharma Business (2018-2023)
11.8.5 Helapet Recent Development
11.9 JWD InfoLogistics Public
11.9.1 JWD InfoLogistics Public Company Detail
11.9.2 JWD InfoLogistics Public Business Overview
11.9.3 JWD InfoLogistics Public Cold-chain Pharma Introduction
11.9.4 JWD InfoLogistics Public Revenue in Cold-chain Pharma Business (2018-2023)
11.9.5 JWD InfoLogistics Public Recent Development
11.10 Kerry Logistics Network Limited
11.10.1 Kerry Logistics Network Limited Company Detail
11.10.2 Kerry Logistics Network Limited Business Overview
11.10.3 Kerry Logistics Network Limited Cold-chain Pharma Introduction
11.10.4 Kerry Logistics Network Limited Revenue in Cold-chain Pharma Business (2018-2023)
11.10.5 Kerry Logistics Network Limited Recent Development
11.11 Kuehne + Nagel Management AG
11.11.1 Kuehne + Nagel Management AG Company Detail
11.11.2 Kuehne + Nagel Management AG Business Overview
11.11.3 Kuehne + Nagel Management AG Cold-chain Pharma Introduction
11.11.4 Kuehne + Nagel Management AG Revenue in Cold-chain Pharma Business (2018-2023)
11.11.5 Kuehne + Nagel Management AG Recent Development
11.12 OOCL Logistics Limited
11.12.1 OOCL Logistics Limited Company Detail
11.12.2 OOCL Logistics Limited Business Overview
11.12.3 OOCL Logistics Limited Cold-chain Pharma Introduction
11.12.4 OOCL Logistics Limited Revenue in Cold-chain Pharma Business (2018-2023)
11.12.5 OOCL Logistics Limited Recent Development
11.13 Orient Overseas International Ltd.
11.13.1 Orient Overseas International Ltd. Company Detail
11.13.2 Orient Overseas International Ltd. Business Overview
11.13.3 Orient Overseas International Ltd. Cold-chain Pharma Introduction
11.13.4 Orient Overseas International Ltd. Revenue in Cold-chain Pharma Business (2018-2023)
11.13.5 Orient Overseas International Ltd. Recent Development
11.14 SCG Logistics
11.14.1 SCG Logistics Company Detail
11.14.2 SCG Logistics Business Overview
11.14.3 SCG Logistics Cold-chain Pharma Introduction
11.14.4 SCG Logistics Revenue in Cold-chain Pharma Business (2018-2023)
11.14.5 SCG Logistics Recent Development
11.15 United Parcel Service
11.15.1 United Parcel Service Company Detail
11.15.2 United Parcel Service Business Overview
11.15.3 United Parcel Service Cold-chain Pharma Introduction
11.15.4 United Parcel Service Revenue in Cold-chain Pharma Business (2018-2023)
11.15.5 United Parcel Service Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Agility Public Warehousing Company KSCP
AmerisourceBergen Corporation
Cavalier Logistics
Continental AG
Deutsche Post AG
DSV A/S
FedEx Corporation
Helapet
JWD InfoLogistics Public
Kerry Logistics Network Limited
Kuehne + Nagel Management AG
OOCL Logistics Limited
Orient Overseas International Ltd.
SCG Logistics
United Parcel Service

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.